• Explore /
  • Poster
  • / Safety and efficacy of eltrombopag (epag) versus placebo (pbo) for the treatment (tx) of chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors receiving gemcitabine (gem)-based chemotherapy (ctx): A phase I study.

Safety and efficacy of eltrombopag (epag) versus placebo (pbo) for the treatment (tx) of chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors receiving gemcitabine (gem)-based chemotherapy (ctx): A phase I study.

Abstract Poster

Authors

null

Eric S. Winer

Rhode Island Hospital, Providence, RI

Eric S. Winer , Howard Safran , Boguslawa Karaszewska , Donald A. Richards , Lee Hartner , Frederic Forget , Rodryg Ramlau , Kirushna Kumar , Bhabita Mayer , Brendan Mark Johnson , Conrad A. Messam , Yasser Mostafa Mostafa Kamel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Patient and Survivor Care

Track

Patient and Survivor Care

Sub Track

Palliative Care and Symptom Management

Clinical Trial Registration Number

NCT01147809

Citation

J Clin Oncol 30, 2012 (suppl; abstr 9117)

DOI

10.1200/jco.2012.30.15_suppl.9117

Abstract #

9117

Poster Bd #

47G

Abstract Disclosures

Similar Posters

First Author: Benedict J. Panizza

First Author: Raed Moh'd Taiseer Al-Rajabi

First Author: Danny Rischin

First Author: Junli Xue